nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiludronate—PTPN1—Posttranslational regulation of adherens junction stability and dissassembly—RET—thyroid cancer	0.0678	0.111	CbGpPWpGaD
Tiludronate—PTPN1—trachea—thyroid cancer	0.0665	0.18	CbGeAlD
Tiludronate—PTPN1—thyroid gland—thyroid cancer	0.0526	0.143	CbGeAlD
Tiludronate—ATP6V1A—saliva-secreting gland—thyroid cancer	0.0517	0.14	CbGeAlD
Tiludronate—PTPN1—head—thyroid cancer	0.0467	0.126	CbGeAlD
Tiludronate—ATP6V1A—Iron uptake and transport—CP—thyroid cancer	0.0465	0.0763	CbGpPWpGaD
Tiludronate—PTPN1—Regulation of IFNA signaling—IFNA2—thyroid cancer	0.0453	0.0743	CbGpPWpGaD
Tiludronate—ATP6V1A—trachea—thyroid cancer	0.0398	0.108	CbGeAlD
Tiludronate—PTPN1—lymph node—thyroid cancer	0.0327	0.0886	CbGeAlD
Tiludronate—ATP6V1A—thyroid gland—thyroid cancer	0.0315	0.0854	CbGeAlD
Tiludronate—ATP6V1A—head—thyroid cancer	0.028	0.0758	CbGeAlD
Tiludronate—PTPN1—Interferon alpha/beta signaling—IFNA2—thyroid cancer	0.0218	0.0357	CbGpPWpGaD
Tiludronate—ATP6V1A—lymph node—thyroid cancer	0.0196	0.0531	CbGeAlD
Tiludronate—PTPN1—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—thyroid cancer	0.0164	0.0268	CbGpPWpGaD
Tiludronate—PTPN1—Interferon Signaling—TPR—thyroid cancer	0.0156	0.0255	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling by Insulin receptor—CDK1—thyroid cancer	0.0142	0.0234	CbGpPWpGaD
Tiludronate—PTPN1—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—thyroid cancer	0.0129	0.0211	CbGpPWpGaD
Tiludronate—PTPN1—IGF1 pathway—HRAS—thyroid cancer	0.011	0.0181	CbGpPWpGaD
Tiludronate—PTPN1—Integrin alphaIIb beta3 signaling—AKT1—thyroid cancer	0.0106	0.0174	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—TPR—thyroid cancer	0.0104	0.017	CbGpPWpGaD
Tiludronate—PTPN1—Interferon Signaling—IFNA2—thyroid cancer	0.0101	0.0166	CbGpPWpGaD
Tiludronate—PTPN1—IGF1 pathway—AKT1—thyroid cancer	0.00974	0.016	CbGpPWpGaD
Tiludronate—PTPN1—Leptin signaling pathway—CCND1—thyroid cancer	0.00841	0.0138	CbGpPWpGaD
Tiludronate—PTPN1—Platelet Aggregation (Plug Formation)—AKT1—thyroid cancer	0.00823	0.0135	CbGpPWpGaD
Tiludronate—PTPN1—Insulin Pathway—HRAS—thyroid cancer	0.00797	0.0131	CbGpPWpGaD
Tiludronate—PTPN1—PDGFR-beta signaling pathway—BRAF—thyroid cancer	0.00766	0.0126	CbGpPWpGaD
Tiludronate—PTPN1—Posttranslational regulation of adherens junction stability and dissassembly—HRAS—thyroid cancer	0.00757	0.0124	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—TRIM24—thyroid cancer	0.0072	0.0118	CbGpPWpGaD
Tiludronate—PTPN1—Insulin Pathway—AKT1—thyroid cancer	0.00704	0.0115	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—CDK1—thyroid cancer	0.00704	0.0115	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—IFNA2—thyroid cancer	0.00677	0.0111	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—CHST14—thyroid cancer	0.00677	0.0111	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—TRIM33—thyroid cancer	0.00641	0.0105	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—PRKAR1A—thyroid cancer	0.00637	0.0104	CbGpPWpGaD
Tiludronate—PTPN1—Signaling events mediated by PTP1B—AKT1—thyroid cancer	0.00627	0.0103	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—RAP1GAP—thyroid cancer	0.00591	0.00969	CbGpPWpGaD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—TPR—thyroid cancer	0.0056	0.00919	CbGpPWpGaD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—CP—thyroid cancer	0.0056	0.00919	CbGpPWpGaD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.00551	0.00904	CbGpPWpGaD
Tiludronate—PTPN1—PDGFR-beta signaling pathway—PTEN—thyroid cancer	0.0054	0.00885	CbGpPWpGaD
Tiludronate—PTPN1—Leptin signaling pathway—HRAS—thyroid cancer	0.0053	0.00869	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling by Insulin receptor—NRAS—thyroid cancer	0.00511	0.00838	CbGpPWpGaD
Tiludronate—PTPN1—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—HRAS—thyroid cancer	0.00503	0.00825	CbGpPWpGaD
Tiludronate—PTPN1—PDGFR-beta signaling pathway—NRAS—thyroid cancer	0.00481	0.00789	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CALCB—thyroid cancer	0.00474	0.00777	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CALCB—thyroid cancer	0.00474	0.00777	CbGpPWpGaD
Tiludronate—PTPN1—Leptin signaling pathway—AKT1—thyroid cancer	0.00468	0.00767	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—TRIM33—thyroid cancer	0.00449	0.00737	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—TRIM33—thyroid cancer	0.00449	0.00737	CbGpPWpGaD
Tiludronate—PTPN1—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—AKT1—thyroid cancer	0.00444	0.00729	CbGpPWpGaD
Tiludronate—PTPN1—Insulin Signaling—PTEN—thyroid cancer	0.00443	0.00726	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling by Insulin receptor—KRAS—thyroid cancer	0.0044	0.00721	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—TCF7L1—thyroid cancer	0.00428	0.00702	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—IFNA2—thyroid cancer	0.00422	0.00692	CbGpPWpGaD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.00419	0.00688	CbGpPWpGaD
Tiludronate—PTPN1—PDGFR-beta signaling pathway—KRAS—thyroid cancer	0.00414	0.00679	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling by Insulin receptor—HRAS—thyroid cancer	0.00374	0.00613	CbGpPWpGaD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.00352	0.00578	CbGpPWpGaD
Tiludronate—PTPN1—PDGFR-beta signaling pathway—HRAS—thyroid cancer	0.00352	0.00578	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—TPR—thyroid cancer	0.00339	0.00556	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—LGALS3—thyroid cancer	0.00337	0.00552	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—PRKAR1A—thyroid cancer	0.00334	0.00547	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—TPR—thyroid cancer	0.00313	0.00514	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PRKAR1A—thyroid cancer	0.00308	0.00505	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—TCF7L1—thyroid cancer	0.003	0.00492	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—TCF7L1—thyroid cancer	0.003	0.00492	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—MEN1—thyroid cancer	0.00295	0.00483	CbGpPWpGaD
Tiludronate—PTPN1—Insulin Signaling—HRAS—thyroid cancer	0.00289	0.00474	CbGpPWpGaD
Tiludronate—PTPN1—Insulin Signaling—AKT1—thyroid cancer	0.00255	0.00419	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—NRAS—thyroid cancer	0.00253	0.00414	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—CALCA—thyroid cancer	0.00235	0.00385	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CDK1—thyroid cancer	0.0023	0.00377	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—IFNA2—thyroid cancer	0.00221	0.00363	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—TSHR—thyroid cancer	0.00219	0.0036	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—TSHR—thyroid cancer	0.00219	0.0036	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—KRAS—thyroid cancer	0.00217	0.00356	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PRKAR1A—thyroid cancer	0.00216	0.00354	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PRKAR1A—thyroid cancer	0.00216	0.00354	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—CDK1—thyroid cancer	0.00212	0.00348	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—MEN1—thyroid cancer	0.00206	0.00338	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—MEN1—thyroid cancer	0.00206	0.00338	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	0.00197	0.00323	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PTCH1—thyroid cancer	0.00187	0.00306	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PTCH1—thyroid cancer	0.00187	0.00306	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—HRAS—thyroid cancer	0.00185	0.00303	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—NRG1—thyroid cancer	0.00185	0.00303	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—SST—thyroid cancer	0.00171	0.0028	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—SST—thyroid cancer	0.00171	0.0028	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—NRG1—thyroid cancer	0.0017	0.00279	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CALCA—thyroid cancer	0.00164	0.00269	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CALCA—thyroid cancer	0.00164	0.00269	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—NRAS—thyroid cancer	0.00157	0.00258	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—TERT—thyroid cancer	0.00153	0.00251	CbGpPWpGaD
Tiludronate—Influenza like illness—Sorafenib—thyroid cancer	0.00149	0.0706	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—CDK1—thyroid cancer	0.00149	0.00244	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CDK1—thyroid cancer	0.00149	0.00244	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—HIF1A—thyroid cancer	0.00146	0.0024	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—KRAS—thyroid cancer	0.00135	0.00222	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—BRAF—thyroid cancer	0.00121	0.00199	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—TP53—thyroid cancer	0.0012	0.00197	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—NRG1—thyroid cancer	0.00119	0.00196	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—NRG1—thyroid cancer	0.00119	0.00196	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—HRAS—thyroid cancer	0.00115	0.00189	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—TERT—thyroid cancer	0.00107	0.00176	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—TERT—thyroid cancer	0.00107	0.00176	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—HIF1A—thyroid cancer	0.00102	0.00168	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—HIF1A—thyroid cancer	0.00102	0.00168	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—AKT1—thyroid cancer	0.00102	0.00167	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PTGS2—thyroid cancer	0.000979	0.00161	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—PTEN—thyroid cancer	0.000924	0.00152	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PTEN—thyroid cancer	0.000853	0.0014	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—BRAF—thyroid cancer	0.000848	0.00139	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—BRAF—thyroid cancer	0.000848	0.00139	CbGpPWpGaD
Tiludronate—Arthralgia—Vandetanib—thyroid cancer	0.000848	0.0401	CcSEcCtD
Tiludronate—PTPN1—Immune System—NRAS—thyroid cancer	0.000825	0.00135	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—NRAS—thyroid cancer	0.000761	0.00125	CbGpPWpGaD
Tiludronate—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.000741	0.035	CcSEcCtD
Tiludronate—Dyspepsia—Vandetanib—thyroid cancer	0.000716	0.0338	CcSEcCtD
Tiludronate—PTPN1—Immune System—KRAS—thyroid cancer	0.00071	0.00116	CbGpPWpGaD
Tiludronate—Pain—Vandetanib—thyroid cancer	0.000695	0.0329	CcSEcCtD
Tiludronate—Gastrointestinal pain—Vandetanib—thyroid cancer	0.000665	0.0314	CcSEcCtD
Tiludronate—ATP6V1A—Disease—KRAS—thyroid cancer	0.000655	0.00107	CbGpPWpGaD
Tiludronate—Abdominal pain—Vandetanib—thyroid cancer	0.000643	0.0304	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—CCND1—thyroid cancer	0.000619	0.00102	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CCND1—thyroid cancer	0.000619	0.00102	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—HRAS—thyroid cancer	0.000603	0.00099	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PTEN—thyroid cancer	0.000598	0.00098	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PTEN—thyroid cancer	0.000598	0.00098	CbGpPWpGaD
Tiludronate—Bone pain—Epirubicin—thyroid cancer	0.000593	0.028	CcSEcCtD
Tiludronate—Asthenia—Vandetanib—thyroid cancer	0.000583	0.0276	CcSEcCtD
Tiludronate—Arthralgia—Sorafenib—thyroid cancer	0.000572	0.0271	CcSEcCtD
Tiludronate—Myalgia—Sorafenib—thyroid cancer	0.000572	0.0271	CcSEcCtD
Tiludronate—ATP6V1A—Disease—HRAS—thyroid cancer	0.000557	0.000914	CbGpPWpGaD
Tiludronate—Diarrhoea—Vandetanib—thyroid cancer	0.000556	0.0263	CcSEcCtD
Tiludronate—Influenza like illness—Epirubicin—thyroid cancer	0.000552	0.0261	CcSEcCtD
Tiludronate—Bone pain—Doxorubicin—thyroid cancer	0.000549	0.0259	CcSEcCtD
Tiludronate—Dizziness—Vandetanib—thyroid cancer	0.000538	0.0254	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—NRAS—thyroid cancer	0.000533	0.000874	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—NRAS—thyroid cancer	0.000533	0.000874	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—AKT1—thyroid cancer	0.000533	0.000874	CbGpPWpGaD
Tiludronate—Influenza like illness—Doxorubicin—thyroid cancer	0.000511	0.0241	CcSEcCtD
Tiludronate—Headache—Vandetanib—thyroid cancer	0.000509	0.0241	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.0005	0.0236	CcSEcCtD
Tiludronate—ATP6V1A—Disease—AKT1—thyroid cancer	0.000492	0.000807	CbGpPWpGaD
Tiludronate—Nausea—Vandetanib—thyroid cancer	0.000483	0.0228	CcSEcCtD
Tiludronate—Dyspepsia—Sorafenib—thyroid cancer	0.000483	0.0228	CcSEcCtD
Tiludronate—Pain—Sorafenib—thyroid cancer	0.000469	0.0222	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—KRAS—thyroid cancer	0.000459	0.000753	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—KRAS—thyroid cancer	0.000459	0.000753	CbGpPWpGaD
Tiludronate—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000449	0.0212	CcSEcCtD
Tiludronate—Abdominal pain—Sorafenib—thyroid cancer	0.000434	0.0205	CcSEcCtD
Tiludronate—PTPN1—Signaling Pathways—TP53—thyroid cancer	0.000408	0.000669	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—TP53—thyroid cancer	0.000408	0.000669	CbGpPWpGaD
Tiludronate—Asthenia—Sorafenib—thyroid cancer	0.000394	0.0186	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—HRAS—thyroid cancer	0.00039	0.00064	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—HRAS—thyroid cancer	0.00039	0.00064	CbGpPWpGaD
Tiludronate—Diarrhoea—Sorafenib—thyroid cancer	0.000375	0.0177	CcSEcCtD
Tiludronate—Dizziness—Sorafenib—thyroid cancer	0.000363	0.0171	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—AKT1—thyroid cancer	0.000344	0.000565	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—AKT1—thyroid cancer	0.000344	0.000565	CbGpPWpGaD
Tiludronate—Headache—Sorafenib—thyroid cancer	0.000344	0.0162	CcSEcCtD
Tiludronate—Nausea—Sorafenib—thyroid cancer	0.000326	0.0154	CcSEcCtD
Tiludronate—Rhinitis—Epirubicin—thyroid cancer	0.000286	0.0135	CcSEcCtD
Tiludronate—Rhinitis—Doxorubicin—thyroid cancer	0.000265	0.0125	CcSEcCtD
Tiludronate—Back pain—Epirubicin—thyroid cancer	0.00024	0.0114	CcSEcCtD
Tiludronate—Vertigo—Epirubicin—thyroid cancer	0.000223	0.0106	CcSEcCtD
Tiludronate—Back pain—Doxorubicin—thyroid cancer	0.000222	0.0105	CcSEcCtD
Tiludronate—Arthralgia—Epirubicin—thyroid cancer	0.000211	0.01	CcSEcCtD
Tiludronate—Myalgia—Epirubicin—thyroid cancer	0.000211	0.01	CcSEcCtD
Tiludronate—Vertigo—Doxorubicin—thyroid cancer	0.000206	0.00976	CcSEcCtD
Tiludronate—Arthralgia—Doxorubicin—thyroid cancer	0.000196	0.00925	CcSEcCtD
Tiludronate—Myalgia—Doxorubicin—thyroid cancer	0.000196	0.00925	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000185	0.00873	CcSEcCtD
Tiludronate—Dyspepsia—Epirubicin—thyroid cancer	0.000178	0.00844	CcSEcCtD
Tiludronate—Pain—Epirubicin—thyroid cancer	0.000173	0.0082	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000171	0.00808	CcSEcCtD
Tiludronate—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000166	0.00784	CcSEcCtD
Tiludronate—Dyspepsia—Doxorubicin—thyroid cancer	0.000165	0.00781	CcSEcCtD
Tiludronate—Pain—Doxorubicin—thyroid cancer	0.00016	0.00758	CcSEcCtD
Tiludronate—Abdominal pain—Epirubicin—thyroid cancer	0.00016	0.00758	CcSEcCtD
Tiludronate—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000153	0.00725	CcSEcCtD
Tiludronate—Abdominal pain—Doxorubicin—thyroid cancer	0.000148	0.00701	CcSEcCtD
Tiludronate—Asthenia—Epirubicin—thyroid cancer	0.000145	0.00688	CcSEcCtD
Tiludronate—Diarrhoea—Epirubicin—thyroid cancer	0.000139	0.00656	CcSEcCtD
Tiludronate—Asthenia—Doxorubicin—thyroid cancer	0.000135	0.00636	CcSEcCtD
Tiludronate—Dizziness—Epirubicin—thyroid cancer	0.000134	0.00634	CcSEcCtD
Tiludronate—Diarrhoea—Doxorubicin—thyroid cancer	0.000128	0.00607	CcSEcCtD
Tiludronate—Headache—Epirubicin—thyroid cancer	0.000127	0.006	CcSEcCtD
Tiludronate—Dizziness—Doxorubicin—thyroid cancer	0.000124	0.00586	CcSEcCtD
Tiludronate—Nausea—Epirubicin—thyroid cancer	0.00012	0.00569	CcSEcCtD
Tiludronate—Headache—Doxorubicin—thyroid cancer	0.000118	0.00556	CcSEcCtD
Tiludronate—Nausea—Doxorubicin—thyroid cancer	0.000111	0.00527	CcSEcCtD
